Biosite secures Mobeus funding

Biosite secures Mobeus funding

Mobeus has provided £4 million of growth capital to Biosite, a fast growing provider of biometric access control and software-based workforce management solutions which facilitate safe and secure sites for the construction sector.

Biosite, which is based in the Midlands and was founded in 2010, is led by Managing Director Dr Li Wang and Research Director Dr Greg Reynolds. Biosite has developed a unique fingerprint algorithm which works with low grade fingerprints (a feature of the construction industry) to provide access control for workers coming on site. Around this, Biosite has developed a software system that allows customers to utilise the data collected from the access control platform to manage their workforce as well as providing broader security services including integrated CCTV, fire alarms and guarding.

Biosite works with a number of the largest construction firms in the UK including Wates, Bouygues, Willmott Dixon and BAM Construction. As well as providing efficiency savings, Biosite assists its customers to meet safety and compliance requirements.  The investment will support the expansion of the Biosite team to facilitate the development of new site-management tools which will enable site managers to oversee all aspects of a construction project under their control.

Mobeus has introduced Mark Roberts, former CEO of CSC, as non-executive Chairman. Roberts led private-equity backed CSC, which provided software to structural engineers, through a period of significant international growth and a successful trade exit to NASDAQ-listed Trimble.

Amit Hindocha from Mobeus, who will join the board of Biosite, said: “We are delighted to be partnering with Li and Greg. They have done an excellent job in establishing Biosite as one of the leading workforce management platforms in the construction industry and our funding will provide them with the capital needed to become the site management tool for the industry.”

Li Wang, Founder and MD of Biosite, said: “This is an exciting time for Biosite; we had a number of investment offers, but in Mobeus we believe we have found the right partner. We are looking forward to working together to capitalise on our growth opportunities.”

– Ends –

Issued by Mobeus Equity Partners LLP, of 30 Haymarket, London SW1Y 4EX, registered in England & Wales number OC320577, authorised and regulated by the Financial Conduct Authority, number 456538. This material is for information only and does not constitute an offer to buy or sell an investment nor does it solicit any such invitation. The information contained in this email is believed to be accurate at the date of publication but no representation or warranty stated or implied is made or given by any person as to its accuracy or completeness and no responsibility or liability is accepted for any such information or opinion.

Return to previous page >